Applied Proteomics, Inc.
SAN DIEGO, CA · CIK 0001548525 · Biotech · Acquired
Protein biomarker discovery platform using proteomics analysis
appliedproteomics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $50M
- 2 Form D · Sep 2013
- 157 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 31
- 1 granted · 30 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2011201220132014
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $22,499,993 | |
| Private capital raised | Form D · SEC | $27,863,715 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3318 | ImmunoGen | — | — |
| 3319 | Cypre, Inc. | — | $3.2M |
| 3320 | Optimeos Life Sciences, Inc. | — | $3.3M |
| 3321 | Applied Proteomics, Inc. | — | $50M |
| 3322 | DNA SEQ 2, INC. | — | $1.2M |
| 3323 | Clasp Therapeutics | — | — |
| 3324 | Cgenetech, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Daniel AbrutynDirector · Executive Officer
- David AgusDirector · Executive Officer
- James BlairDirector
- Daniel HillisDirector · Executive Officer
- Erik HolmlinDirector
- Peter KlemmDirector · Executive Officer
- Kok LimDirector
Patents
- Protein Biomarker Panels For Detecting Colorectal Cancer And Advanced Adenomagranted
- Method For Evaluation Of Presence Of Or Risk Of Colon Tumorsapplication
- Method For Evaluation Of Presence Of Or Risk Of Colon Tumorsapplication
- Method For Evaluation Of Presence Of Or Risk Of Colon Tumorsapplication
- Method For Evaluation Of Presence Of Or Risk Of Colon Tumorsapplication
- Method For Evaluation Of Presence Of Or Risk Of Colon Tumorsapplication
- Instrument and Technical Errorsapplication
- Fraction and Retention Time Errorsapplication
- Pre-Processingapplication
- Peak Protein Assignment Errorsapplication
- Peak ID and MS Errorsapplication
- Protein Biomarker Panels For Detecting Colorectal Cancer And Advanced Adenomaapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.